许清芳, 方晓玲, 陈道峰, 李珺婵. 三七总皂苷鼻腔用制剂的研究J. 药学学报, 2003, 38(11): 859-862.
引用本文: 许清芳, 方晓玲, 陈道峰, 李珺婵. 三七总皂苷鼻腔用制剂的研究J. 药学学报, 2003, 38(11): 859-862.
XU Qing-fang, FANG Xiao-ling, CHEN Dao-feng LI Jun-chan, . Studies on formulations of Panax notoginsenosides for intranasal administrationJ. Acta Pharmaceutica Sinica, 2003, 38(11): 859-862.
Citation: XU Qing-fang, FANG Xiao-ling, CHEN Dao-feng LI Jun-chan, . Studies on formulations of Panax notoginsenosides for intranasal administrationJ. Acta Pharmaceutica Sinica, 2003, 38(11): 859-862.

三七总皂苷鼻腔用制剂的研究

Studies on formulations of Panax notoginsenosides for intranasal administration

  • 摘要: 目的研究能够提高三七总皂苷生物利用度的给药途径和制剂。方法采用鼻腔给药筛选提高药物生物利用度的适宜制剂。结果本试验中制备的制剂在不引起黏膜刺激性的条件下,大幅度提高了PNS的生物利用度。结论可从给药途径和剂型两方面考虑提高药物吸收,降低刺激性。

     

    Abstract: AimTo develop high bioavailability preparations without irritation for Panax notoginsenosides. MethodsThe effects of some additives such as microcrystalline cellulose, β-cyclodextrin and hydroxypropyl cellulose on drug in the preparations were examined. ResultsSaponins of Panax notoginseng (PNS) was absorbed in rabbits more when administered intranasally than through other routines, and the formulations including MCC both gave high bioavailability and low irritation. ConclusionBioavailability of Panax notoginsenosides can be increased through changing routine of administration and formulations.

     

/

返回文章
返回